Telomir Pharmaceuticals Inc Annual Return on Equity ROE, Trends, Fundamental Ratios - CSIMarket
CSIMarket
 


Telomir Pharmaceuticals Inc   (NASDAQ: TELO)

TELO's ROE over the last five Years

Return on Equity, Annual Results, Trends, Rankings, Statistics


Return On Equity (Dec 31 2025)
2025
(Dec 31 2024)
2024
(Dec 31 2023)
2023


Y / Y Equity Change 819.6 % -81.3 % - - -
Y / Y Net Income Change - - - - -
Return On Equity - - - - -


You need to upgrade your Flash Player


Financial Statements
Telomir Pharmaceuticals Inc 's Equity $ 6 Millions Annual TELO's Balance sheet
Telomir Pharmaceuticals Inc 's Annual Income $ -10 Millions Annual TELO's Income Statement
Where are TELO's Income coming from? Visit TELO's Income by Segment





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.